Answers are grounded in this paper and cite their sources.
Following surgical resection of Dukes' B or C colorectal cancers 72 patients have been randomly allocated to receive: 5-fluorouracil; or 5-fluorouracil and levamisole; or no treatment. Adjuvant treatment was continued for one year. 66 patients remain evaluable for up to 24 months. Preliminary results show no significant differences in survival or recurrence rates. Two patients receiving 5-fluorouracil and levamisole developed severe, but reversible, neutropenia. Other side effects were uncommon.
No takes yet. Share an insight, caveat, or question.
Bancewicz et al. (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: